Nasus Pharma Ltd (NSRX) Form 6-K — Oct 8, 2026

$NSRXForm 6-KFiled Oct 8, 2026, 4:30 PM ET0001493152-26-046340Original filing

Nasus Pharma Ltd. held its Annual and Special General Meeting of Shareholders on October 8, 2026, with a quorum present. Shareholders approved all agenda items by the applicable required majority, except for Proposal No. 4 from the meeting notice and proxy statement furnished on Form 6-K on September 4, 2026.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.